Pharmafile Logo

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand

The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to use it for virtually launching a brand!

Over the last year, we’ve learned that pretty much anything you can do in person can also be done virtually. In fact, we now know many things can actually be done more effectively using a virtual or hybrid approach. Additionally, a growing number of stakeholders are becoming “digital natives” who prefer the virtual/hybrid format to in-person meetings. The virtual/hybrid format allows for more frequent touchpoints, including with hard-to-reach healthcare providers (HCPs) and patients. Further, it results in higher qualities and quantities of insights collected.

The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. In this article, we share 10 of the most popular ways to use it for virtually launching a brand, including:

1. Review and coordination of clinical studies

2. Regulatory discussions and planning

3. Market access discussions

4. Treatment pathway profiling

5. Patient journey mapping and PSP development

6. Virtual and hybrid medical education programs (pre-launch)

7. Internal team collaboration

8. Field force training and product rollouts

9. Virtual and hybrid medical education programs (post-launch)

10. Ongoing patient, physician, nurse, and allied healthcare provider advisory boards

Access the full article here to learn more!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Helping Caregivers Stay Organized, Secure, and Informed

Audrey Bond, Founder & CEO of Vaultt, discusses her inspiration behind founding the company, how Vaultt is revolutionizing data-sharing in Canada, common biosecurity and data privacy concerns, her experience with...

Transitioning to the “New Normal”: What This Means for Oncology Care

Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care, shares his thoughts on the importance of patient-centricity in cancer care, current barriers to value-based care in the US...

Making Wearable Technology Scalable and Adoptable

Ilaria Varoli, EVP of Myant Inc., explores Textile Computing™ for remote monitoring, health assessments, pediatric and maternal care, temperature regulation, monitoring of athlete performance, and much more.

Courageous Conversation ep.12: Not Going Back: How COVID Has Changed Clinical Trials

Natalie Yeadon, CEO & Co-Founder at Impetus Digital, provides insight into how COVID has changed clinical trials.

Courageous Conversation ep.11: How to Inspire Creativity with Virtual Working Groups

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on how to inspire creativity with virtual working groups.

Parallel HCP-Patient Advisory Boards: A Customer Story

Learn how a Pharma team engaged both dermatologists and patients with psoriasis in two parallel virtual advisory boards.

Courageous Conversation ep.10: Facial Recognition Software in Healthcare

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on Facial Recognition Software in Healthcare.

Transforming the Future of Health & Aging from a Global Health & Social Impact Approach

Dr. Zayna Khayat, Future Strategist at SE Health, dives into the future of aging and healthcare in Canada, including the roles of emerging technologies, the shift to people-powered healthcare, and...

Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve...

Top-10 ways that Pharma teams can fight the climate crisis

Ten easy steps that individual medical, marketing, clinical, regulatory, and market access teams can take to reduce their own footprints.